Skip to main content

Animations

MJFF Publications

6251 - 6260 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2015
  • 2025
  • 2025
  • 2022
  • 2023
  • 2018
  • 2021
  • 2025
  • 2018
  • Summary Details
    RESTRICTED
    Title: A validation study of the Clinician's Tardive Inventory (CTI)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107812
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Neonatal mitochondrial abnormalities due to PINK1 deficiency: Proteomics reveals early changes relevant to Parkinson׳s disease
    Journal Name: Data in Brief
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.dib.2015.11.070
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Characteristics of hospitalized patients with restless legs syndrome in Hawaiʻi by race/ethnicity
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108038
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Peripheral Immune pattern in a genetic cohort of p.A53T alpha-synuclein carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107853
    Citation Count: 0
  • Summary Details
    OPEN
    Title: More of less: Novel multi-ome profiling of single human neurons
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2022.100110
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms241713435
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s Disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2017.12.092
    Citation Count: 456
  • Summary Details
    OPEN
    Title: Subcortical grey matter changes associated with motor symptoms evaluated by the Unified Parkinson’s disease Rating Scale (part III): A longitudinal study in Parkinson’s disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2021.102745
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonists
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2025.130259
    Citation Count: 0
  • Summary Details
    OPEN
    Title: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled Images
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040
    Citation Count: 609
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.